{
    "root": "949ed273-6b79-4f54-8284-a710082edd77",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE",
    "value": "20241106",
    "ingredients": [
        {
            "name": "DEXMEDETOMIDINE HYDROCHLORIDE",
            "code": "1018WH7F9I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31472"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "SODIUM ACETATE",
            "code": "4550K0SC9B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32954"
        },
        {
            "name": "ACETIC ACID",
            "code": "Q40Q9N063P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15366"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "dexmedetomidine hydrochloride 0.9 % sodium chloride injection alpha 2 -adrenergic receptor agonist indicated : \u2022 sedation initially intubated mechanically ventilated adult patients treatment intensive care setting . administer dexmedetomidine hydrochloride 0.9 % sodium chloride injection continuous infusion exceed 24 hours . ( 1.1 ) \u2022 sedation non-intubated adult patients prior and/or surgical procedures . ( 1.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 individualize titrate dexmedetomidine hydrochloride 0.9 % sodium chloride injection dosing desired effect . ( 2.1 ) \u2022 administer dexmedetomidine hydrochloride 0.9 % sodium chloride injection using controlled infusion device . ( 2.1 ) \u2022 200 mcg/50ml 400 mcg/100 ml single-dose galaxy containers require dilution prior . ( 2.4 ) \u2022 adult intensive care unit sedation : initiate one mcg/kg 10 minutes , followed maintenance infusion 0.2 0.7 mcg/kg/ hour . ( 2.2 ) \u2022 adult procedural sedation : initiate one mcg/kg 10 minutes , followed maintenance infusion initiated 0.6 mcg/kg/ hour titrated achieve desired effect doses ranging 0.2 1 mcg/kg/ hour . ( 2.2 ) \u2022 alternative doses : recommended patients 65 years age awake fiberoptic intubation patients . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "dexmedetomidine hydrochloride 0.9 % sodium chloride injection store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dexmedetomidine hydrochloride 0.9 % sodium chloride injection clear colorless , available 200 mcg/50 ml ( 4 mcg/ml ) 400 mcg/100 ml ( 4 mcg/ml ) 50 ml 100 ml galaxy containers , respectively . galaxy containers intended single dose.discard unused portion . code ndc . container size number containers/carton 2g3492 43066-555-24 galaxy single-dose 50 ml twenty-four ( 24 ) ( 2 x 12 ) -200 mcg/50 ml containers 2g3493 43066-557-12 galaxy single-dose 100 ml twelve ( 12 ) ( 2 x 6 ) -400 mcg/100 ml containers",
    "adverseReactions": "none .",
    "indications_original": "Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is an alpha 2 -adrenergic receptor agonist indicated for: \u2022 Sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. Administer dexmedetomidine hydrochloride in 0.9% sodium chloride injection by continuous infusion not to exceed 24 hours.  ( 1.1 ) \u2022 Sedation of non-intubated adult patients prior to and/or during surgical and other procedures. (1.2)",
    "contraindications_original": "\u2022 Individualize and titrate dexmedetomidine hydrochloride in 0.9% sodium chloride injection dosing to desired clinical effect. (2.1) \u2022 Administer dexmedetomidine hydrochloride in 0.9%\u00a0sodium chloride injection using a controlled infusion device. (2.1) \u2022 The 200 mcg/50mL and 400 mcg/100 mL single-dose Galaxy containers do not require further dilution prior to administration. (2.4) \u2022 For Adult Intensive Care Unit Sedation :  Initiate at one mcg/kg over 10 minutes , followed by a maintenance infusion of 0.2 to 0.7 mcg/kg/ hour .  ( 2.2 ) \u2022 For Adult Procedural Sedation :  Initiate at one mcg/kg over 10 minutes , followed by a maintenance infusion initiated at 0.6 mcg/kg/ hour and titrated to achieve desired clinical effect with doses ranging from 0.2 to 1 mcg/kg/ hour . (2.2) \u2022 Alternative Doses :  Recommended for patients over 65 years of age and awake fiberoptic intubation patients. (2.2)",
    "warningsAndPrecautions_original": "Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F)[See USP Controlled Room Temperature].\n                  Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is clear and colorless, and available as 200\u00a0mcg/50\u00a0mL (4\u00a0mcg/mL) and 400\u00a0mcg/100 mL (4 mcg/mL) in 50 mL and 100 mL Galaxy containers, respectively.  Galaxy containers are intended for single dose.Discard unused portion.\n                  \n                     \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Code\n                              \n                           \n                           \n                              \n                                 NDC No.\n                              \n                           \n                           \n                              \n                                 Container\n                              \n                           \n                           \n                              \n                                 Size\n                              \n                           \n                           \n                              \n                                 Number of Containers/Carton\n                              \n                           \n                        \n                        \n                           \n                              2G3492\n                           \n                           \n                              43066-555-24\n                           \n                           \n                              \n                                 Galaxy single-dose\n                           \n                           \n                              50 mL\n                           \n                           \n                              Twenty-four (24) (2 x 12) -200 mcg/50 mL Containers\n                           \n                        \n                        \n                           \n                              2G3493\n                           \n                           \n                              43066-557-12\n                           \n                           \n                              \n                                 Galaxy single-dose\n                           \n                           \n                              100 mL\n                           \n                           \n                              Twelve (12) (2 x 6) -400 mcg/100 mL Containers",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4466"
        }
    ]
}